Following complaints of non-compliance of rules at the blood bank of state-run Cama and Albess Hospital in south Mumbai, the Food and Drug Administration (FDA), Maharashtra, on Friday suspended its licence under the Drug and Cosmetics Act, 1940.
S T Patil, joint commissioner of drugs at FDA, said, “A complaint against the hospital’s blood bank was received around three months back. On inspection, we found that cleanliness on its premises was not as per the required standards. And, the blood transfusion
officer was not present on duty when we visited the bank,” Patil told Newsline.
As per the Act, it is mandatory for a blood bank to have a blood transfusion officer to monitor the supply of blood units from the respective bank. However, Patil said while one officer was absent for a month, other two shift in-charges were also not present at the bank.
“We asked them to either reduce the working hours of the blood bank, if there weren’t enough staffers or recruit more supervisors. In a 24-hour service, a blood bank has three shifts and needs at least three transfusion officers,” an FDA official said.
The suspension will now continue till the hospital complies with all the requirements listed under the Act.
Dr Rajashri Katke, medical superintendent at Cama hospital, said, “We submitted the compliance report to the FDA on Saturday, and hope to restart the functioning of the blood bank soon.”
Dr Nitin Bavdekar, medical superintendent at state-run JJ hospital, said, “We have not received any request for blood from Cama hospital till now. If there is any need, blood can be dispatched from our blood bank.”